Provident Financial Services, Inc. (PFS) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions ...
BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that new long-term progression free survival ...
Phase II study of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination therapy (SOL+BV; SOLA) in patients with unresectable metastatic colorectal cancer (mCRC). Background: Maintenance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback